Close search filters
Changing filters will change the listed Success Criteria and Techniques
Category
Topic
Search results (83)
Article
New Evernorth EnReachRx model expands its suite of GLP-1 solutions, works to improve patient outcomes and drive value
Read More
Article
Mobile is the future of health care delivery and engagement
Mobile will help transform our fragmented health care system and reorient it around consumers.
Read MoreArticle
Tipping the scales to effectively treat obesity
August 02, 2023
The promise and challenges of semaglutide, a new therapy for weight loss
Article
Easing the impact of GLP-1s
January 11, 2024
With GLP-1 sales forecast to exceed $100 billion, plan sponsors need the tools to control growth and expand access.
Article
Technology and human know-how are shaping the future of chronic care management
December 04, 2023
Today, as technology becomes an evermore integral part of our lives, it is being utilized in numerous ways to improve health care, providing convenience and access while assisting providers and enhanc...
Article
A plan sponsor’s guide to GLP-1 medications for weight loss
GLP-1 medications are FDA-approved specifically for weight loss for more than half the adult population of the United States. Plan sponsors can take action to manage weight and other cardiodiabesity-r...
Read MoreArticle
How Accredo’s specialty pharmacists support patients with highly complex conditions
September 18, 2023
Accredo employs more than 800 specialty pharmacists who are dedicated to educating and assisting patients with rare or complex conditions.
Article
How a specialty pharmacy can help support patients that utilize copay assistance
January 16, 2024
The complex nature of copay assistance programs requires operational agility on the part of specialty pharmacies.
Article
Addressing Health Inequities
October 31, 2022
All too often, a person’s gender, race, education, income or zip code dictates how healthy they are.
Article
Understanding hereditary angioedema (HAE)
March 27, 2024
Breaking down what plan sponsors should know about HAE, its challenges and therapies.